Moderna
Fortune Rankings
- Updated:1/31/24
- Country:U.S.
- Headquarters:Cambridge, Mass.
- Industry:Pharmaceuticals
- CEO:Stéphane Bancel
- Website:https://www.moderna.com
- Ticker:MRNA
- Company type:Public
- Revenues ($M):$9,121
- Profits ($M):$-3,466
- Market value ($M):$38,014
- Number of employees:3,900
Figures are for the latest twelve months ended Sept. 30, 2023. Market value as of Jan. 19, 2024. Source: S&P Global.
- $ millions% change
- Revenues ($M):$19,2634.3%
- Profits ($M):$8,362-31.5%
- Assets ($M):$25,858-
- Total Stockholder Equity ($M):$19,123-
- Profit as % of Revenues:43.4%
- Profits as % of Assets:32.3%
- Profits as % of Stockholder Equity:43.7%
- Earnings Per Share ($):20.12
- EPS % Change (from 2021):-28.9%
- Total Return to Investors (2022):-29.3%
- Overall Score:2.7
- Sector:Health Care
- Sector:Natural resources
- Industry:Pharmaceuticals
- Current All-Star Rank:37
- Previous All-Star Rank:-
- Industry Rank:-
- Previous Industry Rank:-
- Overall Score:-
- Innovation:-
- People Management:-
- Use of Corporate Assets:-
- Social Responsibility:-
- Quality of Management:-
- Financial Soundness:-
- Long-Term Investment Value:-
- Quality of Products/Services:-
- Global Competitiveness:-